Non-steroidal CYP17A1 Inhibitors: Discovery and Assessment-Reference-Cited by-同舟云学术

Non-steroidal CYP17A1 Inhibitors: Discovery and Assessment

Published:2023-05-16 Issue:10 Volume:66 Page:6542-6566
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Wróbel Tomasz M.¹²^ORCID,Jørgensen Flemming Steen²^ORCID,Pandey Amit V.³,Grudzińska Angelika¹,Sharma Katyayani³,Yakubu Jibira³,Björkling Fredrik²^ORCID

Affiliation:

1. Department of Synthesis and Chemical Technology of Pharmaceutical Substances, Faculty of Pharmacy, Medical University of Lublin, Chodźki 4a, 20093 Lublin, Poland

2. Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark

3. Pediatric Endocrinology, Department of Pediatrics, University Children’s Hospital, Inselspital, Bern and Translational Hormone Research Program, Department of Biomedical Research, University of Bern, Freiburgstrasse 15, 3010 Bern, Switzerland

Funder

Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung

Narodowe Centrum Nauki

Swiss Cancer Research Foundation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c00442

Reference197 articles.

1. Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome**Supported in part by grants HD-06308 and Rr-00055 from the United States Public Health Service, Bethesda, Maryland.